Resubmitted revised dosing routine for Libervant to Fda in December 2020, as fully commited Many clinical trials demonstrate that AQST-108...
Aquestive
WARREN, N.J., Dec. 16, 2020 (World NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company centered on establishing and...
Forward-Seeking Assertion This press release features forward-looking statements in the indicating of the Non-public Securities Litigation Reform Act of 1995....
